Cargando…

Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol

BACKGROUND: The objective of focal brachytherapy (BT) is to provide effective prostate cancer control for low-risk disease but with reduced genitourinary, gastrointestinal and sexual side effects in a cost-effective way. OBJECTIVE: The aim of this study is to describe a phase II study examining tech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez Ots, Ana, Bucci, Joseph, Chin, Yaw Sinn, Malouf, David, Howie, Andrew, Enari, Komiti Ese
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JMIR Publications 2016
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923592/ https://www.ncbi.nlm.nih.gov/pubmed/27296781 http://dx.doi.org/10.2196/resprot.5433

Ejemplares similares

Focal therapy for prostate cancer – index lesion treatment vs. hemiablation. A matter of definition
por: Stabile, Armando, et al.
Publicado: (2019)

Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020)

Combination of clinical characteristics and transrectal ultrasound-guided biopsy to predict lobes without significant cancer: application in patient selection for hemiablative focal therapy
por: Jung, Jin-Woo, et al.
Publicado: (2014)

Focal low-dose rate brachytherapy for the treatment of prostate cancer
por: Tong, William Y, et al.
Publicado: (2013)

Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020)

High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina
por: Beriwal, Sushil, et al.
Publicado: (2008)

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
por: Belliveau, C., et al.
Publicado: (2022)

Focal application of low-dose-rate brachytherapy for prostate cancer: a pilot study
por: Mahdavi, S. Sara, et al.
Publicado: (2017)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer
por: Maenhout, Metha, et al.
Publicado: (2017)

MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile
por: Beydoun, Nadine, et al.
Publicado: (2014)

The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).
por: Mendez, Lucas C., et al.
Publicado: (2023)

Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
por: Kunogi, Hiroaki, et al.
Publicado: (2016)

Re-salvage MRI-guided Focal High-dose-rate Brachytherapy for Locally Recurrent Prostate Cancer
por: Van Son, Marieke J, et al.
Publicado: (2018)

Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

Single fraction multimodal image guided focal salvage high-dose-rate brachytherapy for recurrent prostate cancer
por: Zamboglou, Constantinos, et al.
Publicado: (2016)

Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution
por: Anderson, Elliot, et al.
Publicado: (2021)

A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy
por: Slevin, Finbar, et al.
Publicado: (2019)

Low dose rate prostate brachytherapy
por: Stish, Bradley J., et al.
Publicado: (2018)

Preoperative high dose rate brachytherapy for clinical stage II endometrial carcinoma
por: Shukla, Gaurav, et al.
Publicado: (2011)

Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy – a meta-analysis of clinical trials
por: Viani, Gustavo A, et al.
Publicado: (2009)

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer
por: Hathout, Lara, et al.
Publicado: (2019)

Prevention of high-dose-rate brachytherapy accidents
por: Commission Internationale de Protection contre les Radiations
Publicado: (2005)

High Dose Rate Brachytherapy - A Textbook
por: Ash, DV
Publicado: (1995)

Pulsed dose rate brachytherapy of lip cancer
por: Serkies, Krystyna, et al.
Publicado: (2013)

Pulsed dose rate brachytherapy – is it the right way?
por: Skowronek, Janusz
Publicado: (2010)

High dose rate brachytherapy for oral cancer
por: YamazakI, Hideya, et al.
Publicado: (2013)

A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer
por: Murakami, Naoya, et al.
Publicado: (2016)

Perioperative interstitial high-dose-rate brachytherapy for keloids scar
por: Barragán, Victoria Vera, et al.
Publicado: (2022)

Focal salvage high-dose-rate brachytherapy with implantable rectum spacer for locally recurrent prostate cancer after initial low-dose-rate with grade 3 rectal toxicity
por: Opbroek, Thirza, et al.
Publicado: (2023)

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
por: Siva, Shankar, et al.
Publicado: (2018)

Template guided transperineal saturation biopsy of the prostate: lessons for focal and urethra-sparing high-dose-rate brachytherapy for localized prostate cancer
por: Novikov, Sergey Nikolaevich, et al.
Publicado: (2016)

High dose-rate brachytherapy in the treatment of prostate cancer
por: Mendez, Lucas C., et al.
Publicado: (2018)

Comparison of Two High Dose Rate Brachytherapy Regimes
por: Jaswal, Gaurav, et al.
Publicado: (2023)

Timing of High-Dose Rate Brachytherapy With External Beam Radiotherapy in Intermediate and High-Risk Localized Prostate CAncer (THEPCA) Patients and Its Effects on Toxicity and Quality of Life: Protocol of a Randomized Feasibility Trial
por: Palvai, Sreekanth, et al.
Publicado: (2015)

Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design
por: Trachtman, Howard, et al.
Publicado: (2011)

Partial breast irradiation with interstitial high dose-rate brachytherapy in elderly patients: results of a phase II prospective study
por: Palumbo, Isabella, et al.
Publicado: (2009)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy
por: Chapman, Christopher H, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g1f8n5vr5o7080ejkoofj4b9jc